Nath Bio-Genes (India) (BOM:537291) Short-Term Debt: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:537291 Nath Bio-Genes (India) Ltd BOM:537291
71 GF Score
Price ₹152.55
GF Value ₹262.74
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Nath Bio-Genes (India) Short-Term Debt?

Nath Bio-Genes (India) BOM:537291 -0.91% 71 Short-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:537291 with a GF Score™ of 71/100 and a GF Value™ of ₹262.74 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Nath Bio-Genes (India)'s Short-Term Debt for the quarter that ended in Jun. 2026 was ₹0 Mil.

Nath Bio-Genes (India)'s quarterly Short-Term Debt increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹1,212 Mil) but then declined from Mar. 2026 (₹1,212 Mil) to Jun. 2026 (₹0 Mil).

Nath Bio-Genes (India)'s annual Short-Term Debt increased from Mar. 2024 (₹1,055 Mil) to Mar. 2025 (₹1,095 Mil) and increased from Mar. 2025 (₹1,095 Mil) to Mar. 2026 (₹1,212 Mil).

Nath Bio-Genes (India) Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Nath Bio-Genes (India) Short-Term Debt Related Terms

Nath Bio-Genes (India) Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Nath Bio-Genes (India)'s Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nath Bio-Genes (India) Short-Term Debt Chart

Nath Bio-Genes (India) Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 922.94 1,048.09 1,054.81 1,095.24 1,211.79

Nath Bio-Genes (India) Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1,406.27 0.00 1,211.79 0.00
BOM:537291
71GF Score
Nath Bio-Genes (India) Ltd BOM:537291
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of ₹0 Mil mean?
Nath Bio-Genes (India) (BOM:537291) has a Short-Term Debt of ₹0 Mil as of Jun. 2026.
Is Nath Bio-Genes (India)'s Short-Term Debt too high?
Nath Bio-Genes (India)'s current Short-Term Debt is ₹0 Mil. Overall, Nath Bio-Genes (India) has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nath Bio-Genes (India)'s Short-Term Debt compare to CTVA and CF?
Nath Bio-Genes (India)'s Short-Term Debt of ₹0 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for an Agriculture company?
A good Short-Term Debt depends on the Agriculture industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Nath Bio-Genes (India)'s current Short-Term Debt is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nath Bio-Genes (India) stock overvalued right now?
Based on GuruFocus' analysis, Nath Bio-Genes (India) (BOM:537291) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹262.74, compared to a current price of ₹152.55 — trading 41.9% below its estimated fair value. The current Short-Term Debt is ₹0 Mil. Nath Bio-Genes (India)'s overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Nath Bio-Genes (India) (BOM:537291), the current Short-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nath Bio-Genes (India) (BOM:537291) Overvalued in 2026?

Based on GuruFocus' analysis, Nath Bio-Genes (India) stock appears to be undervalued. The current stock price of ₹152.55 is trading 41.9% below its estimated GF Value™ of ₹262.74. GuruFocus considers Nath Bio-Genes (India) to be Significantly Undervalued.

Key valuation signals for BOM:537291:

  • Short-Term Debt: ₹0 Mil
  • GF Value™: ₹262.74 vs. price of ₹152.55 (41.9% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the BOM:537291 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nath Bio-Genes (India) Business Description

Other Exchanges NATHBIOGEN:India
Address 86, Veer Nariman Road, 1, Chateau Windsor, Churchgate, Mumbai, MH, IND, 400 020
Nath Bio-Genes (India) Ltd is engaged in the business of production, processing, and marketing of Hybrid and GM seeds. The company has a product range of field crops, vegetable crops, and micronutrient supplements. It has developed products across verticals of cotton, paddy, mustard, maize, okra, tomato, gourds, chili, and crop nutrition supplements. The operating segments of the group are Agriculture activities; and Trading activities, of which a majority of revenue is derived from the Agriculture activities segment. Geographically, the group has a business presence in India and other countries, of which key revenue is generated within India.
71GF Score

Get the complete analysis for BOM:537291

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹152.55
Price
₹262.74
GF Value